Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Viral Suppression & Decreased Cancer Risk

Ann Intern Med; ePub 2018 Jun 12; Park, et al

Publish date:: July 3, 2018

Antiretroviral therapy (ART) resulting in long-term viral suppression may contribute to cancer prevention, a recent study suggests. In this prospective cohort, researchers sought to determine whether viral suppression is associated with decreased cancer risk in HIV-positive veterans (n=42,441) demographically matched to uninfected veterans (n=104,712) from 1999 to 2015. They found:

Cancer incidence for HIV-positive vs uninfected persons was highest for unsuppressed persons, lower among persons with early suppression, and lowest among those with long-term suppression.
This trend was strongest for AIDS-defining cancer (ADC), much weaker for non-AIDS-defining cancer (NADC), and absent for NADC not caused by viruses.
Patients with long-term viral suppression still had excess cancer risk.

Citation:

Park LS, Tate JP, Sigel K, et al. Association of viral suppression with lower AIDS-defining and non–AIDS-defining cancer incidence in HIV-infected veterans: A prospective cohort study. [Published online ahead of print June 12, 2018]. Ann Intern Med. doi:10.7326/M16-2094.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Infectious Diseases

Obesity, hypoxia predict severity in children with COVID-19,

Prophylactic HIV treatment in female STI patients is rare,

Combo DAA treatments may benefit patients with resistant HCV genotype 3,

Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide,

Opt-out policy at a syringe service program increased HIV/HCV testing,